On the occasion of World Laboratory Day, we celebrate the variety of ways in which modern laboratories can work for the benefit of cancer patients. To give an insight into our unique 3-in-1 laboratory approach, let's take a look at how we unite high-throughput processing, clinical expertise, and research Innovation.
The DKMS Life Science Lab is a pioneering 3-in-1 laboratory, offering a range of specialized services. As one of the world's largest and most advanced genotyping service providers, we specialize in high-resolution, sequence-based HLA typing for stem cell donor registries. However, the services we provide go beyond this. Our lab is uniquely structured into three units: a high throughput laboratory, a clinical laboratory and a research and development laboratory, making us a 3-in-1 laboratory.
High-Throughput Laboratory: The Core of Our Operations
At the heart of our company lies our high throughput laboratory, dedicated to the efficient and automated typing of potential stem cell donors. Our state-of-the-art workflows allow us to process large sample volumes efficiently, enabling cost-effective genotyping on a massive scale.
Clinical Laboratory: Patient-Centered Typing
However, the DKMS Life Science Lab also offers patient-related typing in its clinical laboratory. Work in the clinical laboratory is characterized by manual workflows, processing each sample individually. Depending on the urgency, turnaround times range from 1 to 7 days. Our clinical lab adheres to the highest quality standards and offers both CT and VT typing to meet diverse clinical needs. CT-typing is conducted in full compliance with EFI standards. In addition, the clinical laboratory also offers full genotyping.
Research & Development: Innovating for the Future
Finally, the DKMS Life Science Lab also has a research and development laboratory dedicated to driving innovation in genotyping technologies. Our scientists focus on primer development as well as research into new technologies and advancing genotyping methods. We are also enjoy collaborating with other research centers and universities worldwide to jointly develop new findings and push the boundaries of HLA research and beyond.